Resveratrol, a naturally occurring polyphenol, has been extensively studied for its anti-leukemic activity in CML, particularly through its effects on BCR-ABL-dependent signaling. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.